OncoAlert Colloquium Day 3: Breast cancer

OncoAlert Colloquium Day 2: Lung cancer and MASCC

OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology

The RxPONDER trial and its impact on best clinical practice

Cancer medicine shortages for children around the world

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients

Clinical utility of molecular tumour profiling in breast cancer

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diffuse large B-cell lymphoma.

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patients

Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma